KoreaMed Synapse

157

Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?

Yong Eun Park

KMSID: 1516081345 Intest Res. 2022;20(2):157-158. Published online 2022 April 29 DOI: http://dx.doi.org/10.5217/ir.2022.00041

159

Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?

Sang Hyoung Park

KMSID: 1516081343 Intest Res. 2022;20(2):159-164. Published online 2022 April 29 DOI: http://dx.doi.org/10.5217/ir.2021.00115

165

Artificial intelligence for endoscopy in inflammatory bowel disease

Kento Takenaka, Ami Kawamoto, Ryuichi Okamoto, Mamoru Watanabe, Kazuo Ohtsuka

KMSID: 1516081341 Intest Res. 2022;20(2):165-170. Published online 2022 January 7 DOI: http://dx.doi.org/10.5217/ir.2021.00079

171

SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID

Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seung-Jae Myung

KMSID: 1516081342 Intest Res. 2022;20(2):171-183. Published online 2022 January 5 DOI: http://dx.doi.org/10.5217/ir.2021.00098

184

Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis

Saurabh Kedia, Raju Sharma, Sudheer Kumar Vuyyuru, Deepak Madhu, Pabitra Sahu, Bhaskar Kante, Prasenjit Das, Ankur Goyal, Karan Madan, Govind Makharia, Vineet Ahuja

KMSID: 1516081332 Intest Res. 2022;20(2):184-191. Published online 2021 May 4 DOI: http://dx.doi.org/10.5217/ir.2020.00104

192

Perspectives of East Asian patients and physicians on complementary and alternative medicine use for inflammatory bowel disease: results of a cross-sectional, multinational study

Eun Soo Kim, Chung Hyun Tae, Sung-Ae Jung, Dong Il Park, Jong Pil Im, Chang Soo Eun, Hyuk Yoon, Byung Ik Jang, Haruhiko Ogata, Kayoko Fukuhara, Fumihito Hirai, Kazuo Ohtsuka, Jing Liu, Qian Cao

KMSID: 1516081336 Intest Res. 2022;20(2):192-202. Published online 2022 April 29 DOI: http://dx.doi.org/10.5217/ir.2020.00150

203

Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study

Sun-Ho Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye

KMSID: 1516081334 Intest Res. 2022;20(2):203-212. Published online 2022 April 29 DOI: http://dx.doi.org/10.5217/ir.2021.00020

213

Drug therapy and monitoring for inflammatory bowel disease: a multinational questionnaire investigation in Asia

Chenwen Cai, Juntao Lu, Lijie Lai, Dongjuan Song, Jun Shen, Jinlu Tong, Qing Zheng, Kaichun Wu, Jiaming Qian, Zhihua Ran

KMSID: 1516081335 Intest Res. 2022;20(2):213-223. Published online 2022 April 29 DOI: http://dx.doi.org/10.5217/ir.2021.00031

224

Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease

Meng-Tzu Weng, I-Lun Shih, Chien-Chih Tung, Yew-Loong Leong, Ming-Jium Shieh, Cheng-Yi Wang, Jau-Min Wong, Yen-Hsuan Ni, Shu-Chen Wei

KMSID: 1516081333 Intest Res. 2022;20(2):224-230. Published online 2022 February 8 DOI: http://dx.doi.org/10.5217/ir.2021.00042

231

Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn’s disease: a pilot study

Bhaskar Kante, Pabitra Sahu, Saurabh Kedia, Sudheer K. Vuyyuru, Kapil Soni, Maneesh Singhal, Raju Sharma, Govind Makharia, Vineet Ahuja

KMSID: 1516081337 Intest Res. 2022;20(2):231-239. Published online 2022 February 8 DOI: http://dx.doi.org/10.5217/ir.2021.00056

240

Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis

Fares Ayoub, Matthew Odenwald, Dejan Micic, Sushila R. Dalal, Joel Pekow, Russell D. Cohen, David T. Rubin, Atsushi Sakuraba

KMSID: 1516081339 Intest Res. 2022;20(2):240-250. Published online 2022 February 8 DOI: http://dx.doi.org/10.5217/ir.2021.00091

251

Fecal microbiota transplantation for induction of remission, maintenance and rescue in patients with corticosteroid-dependent ulcerative colitis: a long-term follow-up real-world cohort study

Avnish Kumar Seth, Priti Jain

KMSID: 1516081340 Intest Res. 2022;20(2):251-259. Published online 2022 February 8 DOI: http://dx.doi.org/10.5217/ir.2021.00069

260

One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study

Yuichi Matsuno, Takehiro Torisu, Junji Umeno, Hiroki Shibata, Atsushi Hirano, Yuta Fuyuno, Yasuharu Okamoto, Shin Fujioka, Keisuke Kawasaki, Tomohiko Moriyama, Tomohiro Nagasue, Keizo Zeze, Yoichiro Hirakawa, Shinichiro Kawatoko, Yutaka Koga, Yoshinao Oda, Motohiro Esaki, Takanari Kitazono

KMSID: 1516081344 Intest Res. 2022;20(2):260-268. Published online 2022 April 29 DOI: http://dx.doi.org/10.5217/ir.2021.00124

269

Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis

Nagesh Kamat, Sudheer K Vuyyuru, Saurabh Kedia, Pabitra Sahu, Bhaskar Kante, Peeyush Kumar, Mukesh Kumar Ranjan, Mukesh Kumar Singh, Sambuddha Kumar, Vikas Sachdev, Govind Makharia, Vineet Ahuja

KMSID: 1516081338 Intest Res. 2022;20(2):269-273. Published online 2022 February 8 DOI: http://dx.doi.org/10.5217/ir.2021.00064

274

Endoscopic balloon dilations for strictures of rectum, ileocecal valve and duodenum in a patient with X-linked inhibitor of apoptosis deficiency: a case report

Shinsuke Otagiri, Takehiko Katsurada, Kensuke Sakurai, Junichi Sugita, Naoya Sakamoto

KMSID: 1516081331 Intest Res. 2022;20(2):274-277. Published online 2022 February 8 DOI: http://dx.doi.org/10.5217/ir.2021.00029